Transparency Market Research Respiratory Disease Testing Market-Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 2022 Published Date 19-05-2015
119 Page Report
Buy Now
Request Sample
Press Release
Respiratory Disease Testing Market Expected to Reach USD 3.1 Billion Globally in 2022
Transparency Market Research State Tower, 90, State Street, Suite 700. Albany, NY 12207 United States www.transparencymarketresearch.com sales@transparencymarketresearch.com
Respiratory Market
Disease
Testing
REPORT DESCRIPTION
Respiratory disease tests are required for the diagnosis of any chronic or acute respiratory disorder. The diagnosis of respiratory function is done either by understanding the anatomy of the respiratory organs, or by determining the respiratory capabilities of the lungs. A majority of respiratory tests are designed either to identify obstructions in the respiratory tract, or to observe the efficiency of the lungs in exchanging respiratory gases. Equipment used to detect pulmonary abnormalities hold immense potential due to increasing prevalence of various respiratory diseases such as asthma, chronic obstructive pulmonary disease (COPD), cystic fibrosis, and pneumonia. This research report on the respiratory disease testing market explains various advancements in this market and analyzes the global respiratory disease testing market based on device type, end-user, and geographic regions. This report comprises an elaborate executive summary, which includes a market snapshot that provides market dynamics of various segments and sub-segments that are included in the report in a precise manner.
A detailed qualitative analysis of the factors responsible for driving and restraining the growth of the global respiratory disease testing market and future opportunities has been provided in the market overview section. This section of the report also provides market attractiveness analysis and Porter’s Five Forces analysis and key players’ market share analysis in 2013 in the respiratory disease testing market. The research report also provides value chain (distribution) analysis from the supplier of the raw material to the end-users (hospital, physician offices, and clinical laboratories).
Browse full report at :
http://www.transparencymarketresearch.com/respiratory-disease-testing.html
Based on type of test, the global respiratory disease testing market has been segmented into imaging test, spirometry, peak flow test, blood gas test, lung volume test, and other tests. The market for these tests has been extensively analyzed based on consistency, effectiveness, and sales revenue of the various products developed by the manufacturers. The market size and forecast in terms of USD million for each technology has been provided for the period from 2012
Transparency Market Research
2
Respiratory Market
Disease
Testing
to 2022. The report on the respiratory disease testing market also provides % compound annual growth rate (CAGR) for each of the market segment and sub-segment mentioned above for the forecast period from 2014 to 2022, considering 2013 as the base year.
Based on end-user, the global respiratory disease testing market has been segmented into hospitals, physician offices, and clinical laboratories. The market for these end-users of respiratory disease testing has been extensively analyzed based on installation rate and utilization of the devices in hospitals, physician offices, and clinical laboratories. The market size and forecast in terms of USD million for each segment has been provided for the period from 2012 to 2022. The report on the respiratory disease testing market also provides % compound annual growth rate (CAGR) for each market segment and sub-segment for the forecast period from 2014 to 2022, considering 2013 as the base year.
Browse the full Press Release: http://www.transparencymarketresearch.com/pressrelease/respiratory-disease-testing.htm
Geographically, the respiratory disease testing market has been categorized into North America, Europe, Asia-Pacific, Latin America, Middle East North Africa, and Rest of the World (RoW). The market size and forecast for each of these regions have been provided for the period from 2012 to 2022 along with CAGR (%) for the forecast period from 2014 to 2022. The research study also incorporates the competitive scenario of major players in these regions.
A list of recommendations has been provided for new entrants to help establish a strong presence and for existing market players to increase their market shares. The report concludes with the profiles of major players in the respiratory disease testing market based on various attributes such as company overview, financial overview, business strategies, product portfolio and recent developments. Major players profiled in this report include Philips Healthcare, GE Healthcare, CareFusion Corporation, Cosmed, ndd Medical Technologies, Inc., and SDI Diagnostics.
Transparency Market Research
3
Respiratory Market
Disease
Testing
The global respiratory disease testing market is segmented as follows: Global Respiratory Disease Testing Market, by Test Imaging Tests Spirometry Tests Peak Flow Tests Blood Gas Tests Lung Volume Tests Other Tests Global Respiratory Disease Testing Market, by End-user Hospitals Physician Offices Clinical Laboratories Global Respiratory Disease Testing Market, by Geography North America U.S. Canada Europe U.K. Germany Rest of Europe Asia-Pacific (APAC)
Transparency Market Research
4
Respiratory Market
Disease
Testing
Japan China Rest of APAC Latin America (LATAM) Brazil Mexico Rest of LATAM Middle East North Africa (MENA) Saudi Arabia UAE Rest of MENA Rest of the World
Request a Brochure of this : http://www.transparencymarketresearch.com/sample/sample.php? flag=S&rep_id=1288
About Us
Transparency Market Research is a market intelligence company providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forwardlooking insight for thousands of decision makers.
Transparency Market Research
5
Respiratory Market
Disease
Testing
We are privileged with highly experienced team of Analysts, Researchers and Consultants, who use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.
TABLE OF CONTENT
Chapter 1 Preface 1.1 Report Description 1.2 Market Segmentation 1.3 Research Methodology 1.3.1 Secondary Research 1.3.2 Primary Research 1.3.3 Models 1.3.4 Assumptions 1.4 List of Abbreviations
Chapter 2 Executive Summary 2.1 Market Snapshot: Global Respiratory Disease Testing Market (2013 & 2022) 2.2 Global Respiratory Disease Testing Market, by Tests, 2013 (USD Million)
Transparency Market Research
6
Respiratory Market
Disease
Testing
2.3 Comparative Analysis: Global Respiratory Disease Testing Market, by Geography, 2013 and 2022 (Value %)
Chapter 3 Market Overview 3.1 Overview 3.2 Value Chain Analysis 3.3 Market Drivers 3.3.1 Increasing prevalence of respiratory diseases 3.3.2 Growing geriatric population propels the uptake of respiratory disease testing products 3.3.3 Technological advancements boost demand for respiratory disease testing products 3.4 Restraints 3.4.1 Low adoption rate of digital radiography systems and advanced spirometers 3.5 Opportunities 3.5.1 Capitalizing on the potential presented by emerging markets in Asia-Pacific 3.6 Regulatory Framework 3.7 Porter’s Five Forces Analysis: Global Respiratory Disease Testing Market 3.7.1 Bargaining power of suppliers 3.7.2 Bargaining power of buyers 3.7.3 Threat of substitutes 3.7.4 Threat of new entrants
Transparency Market Research
7
Respiratory Market
Disease
Testing
3.7.5 Competitive rivalry 3.8 Market Attractiveness Analysis: Global Respiratory Disease Testing Market, by Geography 3.9.1 Market Share Analysis, by Key Players: Global Respiratory Disease Testing Market, 2013 (Value %)
Chapter 4 Global Respiratory Disease Testing Market, by Tests 4.1 Overview 4.1.1 Global Respiratory Disease Testing Market Revenue, by Tests, 2012 – 2022 (USD Million) 4.2 Imaging Tests 4.2.1 Global Imaging Test Market Revenue, 2012 – 2022 (USD Million) 4.3 Spirometry 4.3.1 Global Spirometry Test Market Revenue, 2012 – 2022 (USD Million) 4.4 Peak Flow Test 4.4.1 Global Peak Flow Test Market Revenue, 2012 – 2022 (USD Million) 4.5 Blood Gas Test 4.5.1 Global Blood Gas Test Market Revenue, 2012 – 2022 (USD Million) 4.6 Lung Volume Test 4.6.1 Global Lung Volume Test Market Revenue, 2012 – 2022 (USD Million) 4.7 Other Tests (Exercise, Gas transfer, Bronchoscopy, Thoracoscopy, etc.) 4.7.1 Global Other Tests Market Revenue, 2012 – 2022 (USD Million)
Transparency Market Research
8
Respiratory Market
Disease
Testing
Chapter 5 Global Respiratory Disease Testing Market, by End-User 5.1 Overview 5.1.1 Global Respiratory Disease Testing Market Revenue, by End-User, 2012 – 2022 (USD Million) 5.2 Hospitals 5.2.1 Global Hospitals End-User Market Revenue, 2012 – 2022 (USD Million) 5.3 Physician Offices 5.3.1 Global Physician Offices End-User Market Revenue, 2012 – 2022 (USD Million) 5.4 Clinical Laboratories 5.4.1 Global Clinical Laboratories End-User Market Revenue, 2012 – 2022 (USD Million)
Chapter 6 Global Respiratory Disease Testing Market, by Geography 6.1 Overview 6.1.1 Global Respiratory Disease Testing Market Revenue, by Geography, 2012 – 2022 (USD Million) 6.2 North America 6.2.1 North America Respiratory Disease Testing Market Revenue, by Country, 2012 – 2022 (USD Million) 6.2.2 U.S. 6.2.2.1 U.S. Respiratory Disease Testing Market Revenue, 2012 – 2022 (USD Million) 6.2.3 Canada 6.2.3.1 Canada Respiratory Disease Testing Market Revenue, 2012 – 2022 (USD Million)
Transparency Market Research
9
Respiratory Market
Disease
Testing
6.3 Europe 6.3.1 Europe Respiratory Disease Testing Market Revenue, by Country, 2012 – 2022 (USD Million) 6.3.2 U.K. 6.3.2.1 U.K. Respiratory Disease Testing Market Revenue, 2012 – 2022 (USD Million) 6.3.3 Germany 6.3.3.1 Germany Respiratory Disease Testing Market Revenue, 2012 – 2022 (USD Million) 6.3.4 Rest of Europe 6.3.4.1 Rest of Europe Respiratory Disease Testing Market Revenue, 2012 – 2022 (USD Million) 6.4 Asia Pacific 6.4.1 Asia Pacific Respiratory Disease Testing Market Revenue, by Country, 2012 – 2022 (USD Million) 6.4.2 Japan 6.4.2.1 Japan Respiratory Disease Testing Market Revenue, 2012 – 2022 (USD Million) 6.4.3 China 6.4.3.1 China Respiratory Disease Testing Market Revenue, 2012 – 2022 (USD Million) 6.4.4 Rest of Asia Pacific 6.4.4.1 Rest of APAC Respiratory Disease Testing Market Revenue, 2012 – 2022 (USD Million) 6.5 Latin America 6.5.1 Latin America Respiratory Disease Testing Market Revenue, by Country, 2012 – 2022 (USD Million) 6.5.2 Brazil
Transparency Market Research
10
Respiratory Market
Disease
Testing
6.5.2.1 Brazil Respiratory Disease Testing Market Revenue, 2012 – 2022 (USD Million) 6.5.3 Mexico 6.5.3.1 Mexico Respiratory Disease Testing Market Revenue, 2012 – 2022 (USD Million) 6.5.4 Rest of Latin America 6.5.4.1 Rest of LATAM Respiratory Disease Testing Market Revenue, 2012 – 2022 (USD Million) 6.6 Middle East North Africa (MENA) 6.6.1 Middle East North Africa Respiratory Disease Testing Market Revenue, by Country, 2012 – 2022 (USD Million) 6.6.2 Saudi Arabia 6.6.2.1 Saudi Arabia Respiratory Disease Testing Market Revenue, 2012 – 2022 (USD Million) 6.6.3 UAE 6.6.3.1 UAE Respiratory Disease Testing Market Revenue, 2012 – 2022 (USD Million) 6.6.4 Rest of MENA 6.6.4.1 Rest of MENA Respiratory Disease Testing Market Revenue, 2012 – 2022 (USD Million) 6.7 Rest of the World 6.7.1 Rest of the World Respiratory Disease Testing Market Revenue, 2012 – 2022 (USD Million)
Chapter 7 Recommendations 7.1 Market Strategy for Success 7.1.1 Mergers and acquisitions for market expansion
Transparency Market Research
11
Respiratory Market
Disease
Testing
7.1.2 Emphasize on increasing affordability of modern imaging systems 7.1.3 Investing in emerging markets
Chapter 8 Company Profiles 8.1 CareFusion Corporation 8.1.1 Company Overview 8.1.2 Financial Overview 8.1.3 Product Portfolio 8.1.4 Business Strategies 8.1.5 Recent Developments 8.2 Carestream Health, Inc. 8.2.1 Company Overview 8.2.2 Financial Overview 8.2.3 Product portfolio 8.2.4 Business Strategies 8.2.5 Recent Developments 8.3 COSMED 8.3.1 Company Overview 8.3.2 Financial Overview 8.3.3 Product Portfolio
Transparency Market Research
12
Respiratory Market
Disease
Testing
8.3.4 Business Strategies 8.3.5 Recent Developments 8.4 Futuremed America, Inc. 8.4.1 Company Overview 8.4.2 Financial Overview 8.4.3 Product Portfolio 8.4.4 Business Strategies 8.5 GE Healthcare 8.5.1 Company Overview 8.5.2 Financial Overview 8.5.3 Product Portfolio 8.5.4 Business Strategies 8.5.5 Recent Developments 8.6 MGC Diagnostics Corporation 8.6.1 Company Overview 8.6.2 Financial Overview 8.6.3 Product Portfolio 8.6.4 Business Strategies 8.6.5 Recent Developments 8.7 ndd Medical Technologies, Inc.
Transparency Market Research
13
Respiratory Market
Disease
Testing
8.7.1 Company Overview 8.7.2 Financial Overview 8.7.3 Product Portfolio 8.7.4 Business Strategies 8.7.5 Recent Developments 8.8 NIHON KOHDEN CORPORATION 8.8.1 Company Overview 8.8.2 Financial Overview 8.8.3 Product Portfolio 8.8.4 Business Strategies 8.8.5 Recent Developments 8.9 Perkin Elmer, Inc. 8.9.1 Company Overview 8.9.2 Financial Overview 8.9.3 Product Portfolio 8.9.4 Business Strategies 8.9.5 Recent Developments 8.10 Philips Healthcare 8.10.1 Company Overview 8.10.2 Financial Overview
Transparency Market Research
14
Respiratory Market
Disease
Testing
8.10.3 Product Portfolio 8.10.4 Business Strategies 8.10.5 Recent Developments 8.11 SDI Diagnostics 8.11.1 Company Overview 8.11.2 Financial Overview 8.11.3 Product Portfolio 8.11.4 Business Strategies 8.12 Siemens Healthcare 8.12.1 Company Overview 8.12.2 Financial Overview 8.12.3 Product Portfolio 8.12.4 Business Strategies 8.12.5 Recent Developments 8.13 Smiths Medical 8.13.1 Company Overview 8.13.2 Financial Overview 8.13.3 Product Portfolio 8.13.4 Business Strategies 8.13.5 Recent Developments
Transparency Market Research
15
Respiratory Market
Disease
Testing
Contact
Transparency Market Research 90 State Street, Suite 700, Albany NY - 12207 United States Tel: +1-518-618-1030 USA - Canada Toll Free 866-552-3453 Email: sales@transparencymarketresearch.com Website: http://www.transparencymarketresearch.com/
Transparency Market Research
16